Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Data with approximately 3 years of follow-up from the KEYNOTE-407 study show improved survival with pembrolizumab added to chemotherapy
Molecular characterisation of tumours with alterations in the PIK3 pathway
More patients diagnosed with stage IV non-small cell lung cancer presented with brain metastases compared to historic rates
Findings from a large analysis of the GENIE Cohort v8.1
Agents with CNS activity may have improved outcomes for patients with non-small cell lung cancer and brain metastases at diagnosis
A deep-learning algorithm can help to discriminate radiation pneumonitis from COVID-19 pneumonia
It is needed to understand if the cause of disparity is related to reduced access to supportive care or post-protocol therapy
Findings from the COVID-19 and Cancer Consortium
Evidence for efficacy is based on the results from the ZUMA-5 study
Cancer types where TMB-H does not predict response generally show no relationship between tumour neoantigen load and CD8 T-cell infiltration
Existing warning on ifosfamide-induced encephalopathy in the product information should be updated with the latest information on this side effect
Results of an updated integrated analysis of the ALKA-372-001, STARTRK-1, and STARTRK-2
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
